Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B
The Journal of Infectious Diseases · 23.09.2024 · 230 (3) · 545-557
DOI: 10.1093/infdis/jiae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 19.01.2024. Verfasst von Ying Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles,…. Hauptthemen laut MEDLINE: Clostridioides difficile, Anti-Inflammatory Agents, Loratadine, Leukocytes, Mononuclear. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CCF, China Scholarship Council, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Clostridium difficile infection (CDI) is a debilitating nosocomial infection. C. difficile produces toxins A and B, which cause inflammation. Existing therapies have issues with recurrence, cost, and safety. We aim to discover a safe, effective, and economical nonmicrobiological therapeutic approach against CDI.
Methods
We included human primary peripheral blood mononuclear cells (PBMCs), fresh human colonic explants, and humanized HuCD34-NCG mice. Toxin A+B+ VPI 10463 and A−B+ ribotype 017 C. difficile strains were used. We used single-cell RNA profiling and high-throughput screening to find actionable toxin B–dependent pathways in PBMCs.
Results
Histamine 1 receptor–related drugs were found among the hit compounds that reversed toxin-mediated macrophage inflammatory protein (MIP) 1α expression in PBMCs. We identified loratadine as the safest representative antihistamine for therapeutic development. Loratadine inhibited toxin B–induced MIP-1α secretion in fresh human colonic tissues. Oral loratadine (10 mg/kg/d) maintained survival, inhibited intestinal CCl3 messenger RNA expression, and prevented vancomycin-associated recurrence in the VPI 10463–infected mice and ribotype 017-infected hamsters. Splenocytes from loratadine-treated mice conferred anti-inflammatory effects to the VPI 10463–infected T/B-cell–deficient Rag−/− mice. Oral loratadine suppressed human MIP-1α expression in monocytes/macrophages in toxin B–expressing ribotype 017-infected humanized HuCD34-NCG mice.
Conclusions
Loratadine may be repurposed to optimize existing therapies against CDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA.
- Department of Gastroenterology, The First Hospital of China Medical University, Shenyang City, China.
- Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USA.
ORCID-Profile: Ying Xie, Sophie Irwin, Andrea Chupina Estrada, Becca Nelson, Ashlen Bullock, Lindsey Fontenot, Hanping Feng, Mingjun Sun, Hon Wai Koon
Förderung
- CCF
- China Scholarship Council
- NIAID NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
- Crohn’s & Colitis Foundation
Zitieren
APA
Xie, Y., Irwin, S., Chupina Estrada, A., Nelson, B., Bullock, A., Fontenot, L., Feng, H., Sun, M., & Koon, H. W. (2024). Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B. The Journal of Infectious Diseases, 230(3), 545-557. https://doi.org/10.1093/infdis/jiae021
Vancouver
Xie Y, Irwin S, Chupina Estrada A, Nelson B, Bullock A, Fontenot L, et al. Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B. The Journal of Infectious Diseases. 2024;230(3):545-557. doi:10.1093/infdis/jiae021
BibTeX
@article{Xie2024,
author = {Xie, Ying and Irwin, Sophie and Chupina Estrada, Andrea and Nelson, Becca and Bullock, Ashlen and Fontenot, Lindsey and Feng, Hanping and Sun, Mingjun and Koon, Hon Wai},
title = {Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {3},
pages = {545--557},
doi = {10.1093/infdis/jiae021}
}
EUVIMED